1. Home
  2. MNKD vs NSP Comparison

MNKD vs NSP Comparison

Compare MNKD & NSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • NSP
  • Stock Information
  • Founded
  • MNKD 1991
  • NSP 1986
  • Country
  • MNKD United States
  • NSP United States
  • Employees
  • MNKD N/A
  • NSP N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • NSP Professional Services
  • Sector
  • MNKD Health Care
  • NSP Consumer Discretionary
  • Exchange
  • MNKD Nasdaq
  • NSP Nasdaq
  • Market Cap
  • MNKD 1.7B
  • NSP 2.0B
  • IPO Year
  • MNKD 2004
  • NSP 1997
  • Fundamental
  • Price
  • MNKD $5.72
  • NSP $48.36
  • Analyst Decision
  • MNKD Strong Buy
  • NSP Hold
  • Analyst Count
  • MNKD 5
  • NSP 3
  • Target Price
  • MNKD $10.80
  • NSP $58.33
  • AVG Volume (30 Days)
  • MNKD 3.8M
  • NSP 558.1K
  • Earning Date
  • MNKD 11-06-2025
  • NSP 10-30-2025
  • Dividend Yield
  • MNKD N/A
  • NSP 4.95%
  • EPS Growth
  • MNKD 149.32
  • NSP N/A
  • EPS
  • MNKD 0.11
  • NSP 1.05
  • Revenue
  • MNKD $301,736,000.00
  • NSP $6,695,000,000.00
  • Revenue This Year
  • MNKD $16.36
  • NSP $5.06
  • Revenue Next Year
  • MNKD $20.34
  • NSP $5.35
  • P/E Ratio
  • MNKD $52.68
  • NSP $46.05
  • Revenue Growth
  • MNKD 21.48
  • NSP 2.40
  • 52 Week Low
  • MNKD $3.38
  • NSP $44.14
  • 52 Week High
  • MNKD $7.63
  • NSP $95.98
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 63.58
  • NSP 35.67
  • Support Level
  • MNKD $5.33
  • NSP $47.99
  • Resistance Level
  • MNKD $5.90
  • NSP $50.09
  • Average True Range (ATR)
  • MNKD 0.21
  • NSP 1.41
  • MACD
  • MNKD -0.02
  • NSP -0.08
  • Stochastic Oscillator
  • MNKD 77.46
  • NSP 8.45

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About NSP Insperity Inc.

Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.

Share on Social Networks: